Close
American Drug Delivery & Formulation Summit
Xylem

Press Releases

PharmaLytica Expo to aid in chalking out pharma industry’s $130 Billion growth story by 2030

The 8th edition of PharmaLytica Expo opened its doors to industry professionals at the Bombay Exhibition Centre, Mumbai. The event had a grand opening in the presence of key dignitaries Mr. K. G. Ananthakrishnan, Director General โ€“ OPPI, Mr....

Vetter publishes first sustainability report

Vetter, a global leading Contract Development and Manufacturing Organization (CDMO), has published its first sustainability report. The report underpins the company commitment to sustainable action and covers three areas: Ecological Responsibility, Sustainable Economy, and Social Engagement. In doing so,...

Iristick Smart Glasses debuts- Microsoft Teams on Iristick

Iristick, leading supplier of industrial and medical smart glasses announced the launch of Microsoft Teams video conferencing solution on their products. Fully optimized for use with voice commands, โ€˜Microsoft Teams on Iristick helps healthcare professionals improve patient outcome and...

EMA guidance supports development of new antibiotics

EMA to support a global approach to the development of new antimicrobial medicines published the final revised guideline on the evaluation of human medicines for the treatment of bacterial infections. Antimicrobial resistanceย (AMR), which is the ability of microorganisms to resist...

DFE Pharma opens its new Center of Excellence in India to provide fast-track formulation services

DFE Pharma, a global leader in pharma- and nutraceutical excipient solutions, announced the launch ofย its new Center of Excellence โ€œCloser to the Formulatorโ€ (C2F) in Hyderabad, India. The C2F center is based in Genome Valley, a hub of major...

PIPAc Collaboration Enables New Compact, Mobile and Frugal Approach to Active Pharmaceutical Ingredient (API) Manufacturing

The companies NovAliX, Alysophil, De Dietrich Process Systems and Bruker have joined forces to bring to market a new approach to active pharmaceutical ingredient (API) production. The partnership will leverage its complementary skills to provide a complete, standalone, and...

DFE Pharma expands its inhalation portfolio with the launch of Lactohaleยฎ 400

DFE Pharma, a global leader in pharma- and nutraceutical excipient solutions, announced the expansion of its Dry Powder Inhalation (DPI) portfolio with the launch of Lactohaleยฎ 400. The addition of Lactohaleยฎ 400 further enhances the completeness of DFE Pharmaโ€™s portfolio...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป